BioCentury
ARTICLE | Company News

Cell Signaling Technology, Cepheid deal

August 12, 2013 7:00 AM UTC

Cell Signaling granted Cepheid a non-exclusive, worldwide license to Cell Signaling's patents covering the detection of anaplastic lymphoma kinase (ALK) gene rearrangements for the field of PCR diagn...